Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05335252 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dronabinol After Arthroscopic Surgery

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Dec 2026 → Dec 2027
See other at-risk trials from Northwestern University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Dec 2026 to Dec 2027
    • Study completion pushed from Jun 2027 to Jun 2028
    • Eligibility criteria expanded, about 31 words
    • Secondary endpoints: details revised at 3 of 4 entries
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v8
  3. Primary completion date: Dec 2024 to Dec 2026
    • Study completion date: Jun 2025 to Jun 2027
    • Site contact updated
    v7
  4. Primary completion date: Dec 2023 to Dec 2024
    • Study completion date: Jun 2024 to Jun 2025
    v6
  5. Primary completion date: Feb 2023 to Dec 2023
    • Study completion date: Aug 2023 to Jun 2024
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Primary completion date: Dec 2022 to Feb 2023
    • Study completion date: Jun 2023 to Aug 2023
    • Start date changed from estimate of May 2022 to Jun 28, 2022
    • Site details revised
  2. Primary endpoints: 3 to 1
    • Secondary endpoints: 2 to 4
    • Eligibility criteria shortened, about 4 words
    v3
  3. Primary endpoints revised (3)
    • Eligibility criteria expanded, about 2 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the proposed study is to evaluate the efficacy of dronabinol for postoperative pain after arthroscopic surgery of the knee. The investigators hypothesize that dronabinol will relieve pain, reduce opioid consumption and will result in few negative side effects. If this pilot study shows promising results the investigators will expand the trial to include additional arthroscopic surgeries (hip, shoulder) and other types of orthopaedic surgery.
Trial Details
NCT Number NCT05335252
Lead Sponsor Northwestern University
Conditions
(from sponsor)		 Knee Osteoarthritis, Knee Injuries, Meniscus Tear, Synovitis of Knee, Knee Ligament Injury, Chondral Injury of Left Knee, Chondral Injury of Right Knee, Loose Body Knee
Related terms Knee Injuries, Osteoarthritis, Knee
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov